Logo

William Audeh

May 12, 2016

Agendia has appointed William Audeh as chief medical officer. Audeh will report to CEO Mark Straley and is responsible for translating complex laboratory science and personalized medicine diagnostics into actionable, patient-centered solutions for clinicians. Prior to joining Agendia, he served as the director of the Cedars-Sinai Cancer Center, medical director of the Wasserman Breast Cancer Risk Reduction Program, and associate clinical professor of medicine at the University of California, Los Angeles David Geffen School of Medicine. Audeh has also been the principal investigator on a wide variety of both national and international clinical and translational trials, and has authored numerous publications in the field of breast cancer, cancer genomics, and targeted cancer therapy.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.